SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

LIBERATORE JR., Raphael Del Roio  and  DAMIANI, Durval. Bomba de infusão de insulina em diabetes melito tipo 1. J. Pediatr. (Rio J.) [online]. 2006, vol.82, n.4, pp. 249-254. ISSN 0021-7557.  http://dx.doi.org/10.1590/S0021-75572006000500004.

    1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977-86. [ Links ]

    2. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837-53. [ Links ]

    3. Lenhard MJ, Reeves GD. Continuous subcutaneous insulin infusion. Arch Intern Med. 2001;161:2293-300. [ Links ]

    4. Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics. 2001;107:351-6. [ Links ]

    5. Bode BW, Sabbah HT, Gross TM, Fredrickson LP, Davidson PC. Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev. 2002;18:S14-20. [ Links ]

    6. Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979;300:573-8. [ Links ]

    7. Marcus AO, Fernandez MP. Insulin pump therapy. Postgrad Med. 1996;99:125-32. [ Links ]

    8. Plodkowski RA, Edelman SV. The state of insulin pump therapy:2002. Curr Opin Endocrinol Diabetes. 2002;9:329-37. [ Links ]

    9. Raskin P, Holcombe JH, Tamborlane WV, Malone JI, Strowig S, Ahern JA, et al. A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump. J Diabetes Complications. 2001;15:295-300. [ Links ]

    10. Renner R, Pfutzner A, Trautmann M, Harzer O, Sauter K, Landgraf R. Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Diabetes Care. 1999;22:784-8. [ Links ]

    11. Wolpert HA, Faradji RN, Bonner-Weir S, Lipes MA. Metabolic decompensation in pump users due to lispro insulin precipitation. BMJ. 2002;324:1253. [ Links ]

    12. Bode B, Weinstein R, Bell D, McGill J, Nadeau D, Raskin P, et al. Comparison of insulin aspart with buffered regular insulin and insulin lispro is continuous subcutaneous insulin infusion. Diabetes Care. 2002;25:439-44. [ Links ]

    13. Reichel A, Rietzsch H, Kohler HJ, Pfutzner A, Gudat U, Schulze J. Cessation of insulin infusion at night-time during CSII-therapy; comparison of regular human insulin and insulin lispro. Exp Clin Endocrinol Diabetes. 1998;106:168-72. [ Links ]

    14. American Diabetes Association. Continuous subcutaneous insulin infusion. Diabetes Care. 2003;26:S125. [ Links ]

    15. Steindel BS, Roe TR, Costin G, Carlson M, Kaufman FR. Continuous subcutaneous insulin infusion in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res Clin Pract. 1995;27:199-204. [ Links ]

    16. Tamborlane WV, Bonfig W, Boland E. Recent advances in the treatment of youth with type 1 diabetes: better care through technology. Diabet Med. 2001;18;864-70. [ Links ]

    17. DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ, Dutch Insulin Pump Study Group. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care. 2002;25:2074-80. [ Links ]

    18. Ahern JA, Boland EA, Doane R, Ahern JJ, Rose P, Vincent M, et al. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes. 2002:3:10-5. [ Links ]

    19. Plotnick LP, Clark LM, Brancati FL, Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care. 2003;26:1142-6. [ Links ]

    20. Klingensmith GJ, Temple-Trujillo R, Johnson D. Pump therapy for children: weighing the risks and benefits. Diabetes Spectr. 2001;14:81-3. [ Links ]

    21. Litton J, Rice A, Friedman N, Oden J, Lee MM, Freemark M. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr. 2002;141:490-5. [ Links ]

    22. Conrad SC, McGrath MT, Gitelman SE. Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus. J Pediatr. 2002;140:235-40. [ Links ]

    23. Farkas-Hirsch R, Hirsch IB. Continuous subcutaneous insulin infusion: a review of the past and its implementation for the future. Diabetes Spectr. 1994;7:80-4. [ Links ]

    24. Artiles-Sisk A, Buccino J, Pearlman K, Danemann D and the Diabetes Team. Pump therapy in children and teens with type 1 diabetes. Can J Diabetes Care. 2001;25:89A. [ Links ]

    25. Weintrob N, Benzaquen H, Shalitin S, Fayman G, Galatzer A, Dickerman Z, et al. Continuous subcutaneous insulin infusion versus multiple daily injections in children with type 1 diabetes. Diabetologia. 2001;44:A26 [ Links ]

    26. Howard CP, Pettis D, Schurig JM. Use of continuous subcutaneous insulin infusion therapy in a pediatric type 1 diabetes mellitus population. Diabetes. 2000;49:A359. [ Links ]

    27. Liberatore R Jr., Pearlman K, Buccino J, Artiles-Sisk A, Daneman D. Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2004;17:223-6. [ Links ]

    28. Silverstein J, Klingensmith G, Copeland K, Plotnick L. Kaufman F, Laffel L, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005;28:186-212. [ Links ]

    29. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control and enhance coping in adolescents with type 1 diabetes. Diabetes Care. 1999;22:1779-84. [ Links ]

    30. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years. Evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care. 2002;25:593-8. [ Links ]

    31. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes; meta-analysis of randomised controlled trials. BMJ. 2002;324:705. [ Links ]

    32. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy. A meta-analysis. Diabetes Care. 2003;26:1079-87. [ Links ]

    33. Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics. 2003;112:559-64. [ Links ]

    34. Hissa MH, Hissa AS, Bruin VM, Fredrickson LP. Comparison between continuous subcutaneous insulin infusion and multiple insulin injection therapy in type 1 diabetes mellitus; 18-month follow-up. Endocr Pract. 2002;8:411-6. [ Links ]

    35. Renard E. Intensive insulin therapy today: "basal-bolus" using multiple daily injections or CSII? Diabetes Metab. 2005;31:4S40-4S44. [ Links ]

    36. Alemzadeh R, Palma-Sisto P, Parton EA, Holzum MK. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes. Diabetes Technol Ther. 2005;7:587-96. [ Links ]

    37. Kanakis SJ, Watts C, Leichter SB. The business of insulin pumps in diabetes care; clinical and economic considerations. Clinical Diabetes. 2002;20:214-6. [ Links ]

    38. National Institute for Clinical Excellence. Guidance on the use of continuous subcutaneous insulin infusion for diabetes. Technol Appraisal Guidance. 2003;57:1-23. [ Links ]

    39. Feltbower RG, Campbell FM, Bodansky HJ, Stephenson CR, McKinney PA. Insulin pump therapy in childhood diabetes-cost implications for Primary Care Trusts. Diabet Med. 2006;23:86-9. [ Links ]

    40. Mecklenburg RS, Benson EA, Benson JW Jr., Fredlund PN, Guinn T, Metz RJ, et al. Acute complications associated with insulin infusion pump therapy. JAMA. 1984;252:3265-9. [ Links ]

    41. Mack-Fogg JE, Orlowski CC, Jospe N. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective. Pediatr Diabetes. 2005;6:17-21. [ Links ]

    42. Griffin ME, Feder A, Tamborlane WV. Lipoatrophy associated with lispro insulin in insulin pump therapy. Diabetes Care. 2001;24:174. [ Links ]

    43. Raile K, Noelle V, Landgraf R, Scharz HP. Weight in adolescents with type 1 diabetes mellitus during continuous subcutaneous insulin infusion therapy. J Pediatr Endocrinol Metab. 2002;15:607-12. [ Links ]

    44. Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH, et al. Performance evaluation of the MiniMed® continuous glucose monitoring system during patient home use. Diabetes Technol Ther. 2000;2:49-56. [ Links ]

    45. Steil GM, Panteleon AE, Rebrin K. Closed-loop insulin delivery - the path to physiological glucose control. Adv Drug Deliv Rev. 2004;56:125-44. [ Links ]